This information was published on 2019-02-21T12:56:51 for IP Right Acceptance Published.
| Field | Value |
| (210) | 1955097 (IR 1422763) |
| (220) |
28 Jul 2018
|
| (300) |
US, 29 Mar 2018, 87855182
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of cystic fibrosis |
| (540) | ALYFTREO |
| (550) | Word |
| (730) |
Vertex Pharmaceuticals Incorporated
|
Find out more about publications on the About page.